To stem the growing opioid crisis, the U.S. Drug Enforcement Administration (DEA) in 2018 temporarily placed the synthetic opioid fentanyl and its variants in the highest legal and regulatory category, Schedule I, on par with highly addictive substances like heroin and ecstasy. In January 2020, just before that ban was set to expire, the Senate unanimously passed the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act (S. 3201), which would maintain fentanyl variants’ classification as Schedule I drugs for 15 additional months, through May 2021. The bill faced more difficulty in the House, where partisan disagreements…

A national survey on drug use and health, conducted in 2013 by the Substance Abuse and Mental Health Services Administration, found that an estimated 1.9 million people in the United States suffered from substance use disorders related to prescription pain medicines and 517,000 suffered from a heroin use disorder. In the last year, Congress has held several hearings on the what is now considered to be a public health epidemic. These included: Two House Energy and Commerce Oversight and Investigations Subcommittee hearings: one on April 23, titled “Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives” and one on May…